Ben Tre Pharmaceutical JSC (HOSE:DBT)

HOSE:DBT Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	18,549	7,863	20,648	33,102	45,956	68,167
Short-Term Investments	-	-	-	49,000	37,181	37,417
Trading Asset Securities	39,493	39,493	39,493	-	-	-
Cash & Short-Term Investments	58,042	47,356	60,141	82,102	83,136	105,584
Cash Growth	-31.38%	-21.26%	-26.75%	-1.24%	-21.26%	71.55%
Accounts Receivable	176,403	168,118	170,555	132,844	153,568	144,752
Other Receivables	1,172	799.92	1,150	12,189	21,875	9,373
Receivables	188,575	179,918	191,705	145,033	175,444	154,125
Inventory	428,765	470,128	355,921	279,794	174,022	180,418
Prepaid Expenses	4,501	2,082	1,617	631.51	1,402	673.31
Other Current Assets	50,192	42,851	79,528	17,255	9,919	8,693
Total Current Assets	730,075	742,335	688,912	524,815	443,922	449,493
Property, Plant & Equipment	121,368	124,289	66,622	81,384	85,170	88,287
Long-Term Investments	-	-	39,768	50,978	54,467	58,226
Goodwill	33,368	34,383	903.27	4,844	6,137	6,896
Other Intangible Assets	6,647	6,847	7,388	4,002	4,306	5,563
Long-Term Deferred Tax Assets	13,965	12,738	10,942	-	1,187	1,048
Other Long-Term Assets	74,459	73,164	41,072	33,792	22,206	7,529
Total Assets	979,882	993,757	855,608	699,815	617,395	617,043
Accounts Payable	74,864	117,197	83,814	124,933	130,527	129,649
Accrued Expenses	20,411	30,514	34,049	3,852	9,271	13,985
Short-Term Debt	550,510	501,163	458,737	314,867	221,180	219,923
Current Portion of Long-Term Debt	6,891	7,556	4,693	-	-	-
Current Portion of Leases	7,049	7,092	1,684	-	-	-
Current Income Taxes Payable	-	9,340	10,037	4,407	4,750	1,255
Current Unearned Revenue	532.71	489.38	272.66	180	163.64	163.64
Other Current Liabilities	2,725	2,376	3,066	1,953	11,327	1,645
Total Current Liabilities	662,982	675,728	596,352	450,191	377,218	366,620
Long-Term Debt	18,480	19,806	8,335	11,461	-	-
Long-Term Leases	7,690	9,421	2,966	-	-	-
Long-Term Unearned Revenue	1,878	1,976	-	-	-	-
Long-Term Deferred Tax Liabilities	2,705	2,721	-	597.52	280.34	-
Other Long-Term Liabilities	70.44	70.44	70.44	130.5	93	99
Total Liabilities	693,805	709,724	607,723	462,380	377,592	366,719
Common Stock	205,307	205,307	163,255	135,288	123,145	123,145
Additional Paid-In Capital	383.06	383.06	523.06	433.06	538.06	538.06
Retained Earnings	59,824	57,168	73,551	42,986	43,273	53,995
Comprehensive Income & Other	2,587	2,587	2,587	2,587	2,587	2,587
Total Common Equity	268,100	265,444	239,916	181,294	169,542	180,265
Minority Interest	17,977	18,589	7,969	56,141	70,261	70,058
Shareholders' Equity	286,077	284,033	247,885	237,435	239,804	250,323
Total Liabilities & Equity	979,882	993,757	855,608	699,815	617,395	617,043
Total Debt	590,620	545,039	476,414	326,328	221,180	219,923
Net Cash (Debt)	-532,578	-497,683	-416,273	-244,226	-138,044	-114,339
Net Cash Per Share	-25940.64	-28498.34	-26212.79	-	-	-7104.37
Filing Date Shares Outstanding	20.53	20.53	15.88	-	-	16.09
Total Common Shares Outstanding	20.53	20.53	15.88	-	-	16.09
Working Capital	67,093	66,607	92,560	74,624	66,704	82,873
Book Value Per Share	13058.53	12929.17	15107.55	-	-	11200.66
Tangible Book Value	228,085	224,214	231,624	172,448	159,100	167,806
Tangible Book Value Per Share	11109.49	10920.93	14585.42	-	-	10426.54
Buildings	103,794	103,327	62,220	-	-	-
Machinery	85,190	85,178	67,936	-	-	-
Construction In Progress	482.5	482.5	7,759	2,000	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.